Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent

Authors

Devika P. Bagchi, Washington University School of Medicine in St. Louis
Lihai Yu, Washington University School of Medicine in St. Louis
Joel S. Perlmutter, Washington University School of Medicine in St. Louis
Jinbin Xu, Washington University School of Medicine in St. Louis
Robert H. Mach, Washington University School of Medicine in St. LouisFollow
Zhude Tu, Washington University School of Medicine in St. Louis
Paul T. Kotzbauer, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2013

Volume

8

Issue

2

Inclusive Pages

e55031

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0055031

Rights and Permissions

Bagchi DP, Yu L, Perlmutter JS, Xu J, Mach RH, et al. (2013) Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent. PLoS ONE 8(2): e55031. doi:10.1371/journal.pone.0055031

Recommended Citation

Bagchi, Devika P.; Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude; and Kotzbauer, Paul T., "Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent." PLoS One. 8, 2. e55031. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1347